Clinical Trial Update: Evaluation of Pneumococcal Vaccine Formulations in Elderly [Phase 1]

View source ↗

Summary

GlaxoSmithKline conducted a Phase 1 evaluation of pneumococcal vaccine formulations in elderly adults; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infections

Drugs mentioned

• Pneumococcal vaccine formulation (GSK) (Pneumococcal vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Streptococcal | Phase 1 | Status: COMPLETED